Table 2.
Repeated measures ANOVA statistics for QRS complexes.
| Virus | Macaque | Sex | Dose £ | TTD δ | F-Statistic | p-Value |
|---|---|---|---|---|---|---|
| EEEV | M161-16 | M | 8.2 | 6 | 4.780 | 0.0346 * |
| M163-16 | M | 7.5 | 6 | 4.034 | 0.0490 * | |
| M160-16 | M | 7.0 | S | 3.833 | 0.058 | |
| M162-16 | M | 5.7 | S | 3.046 | 0.331 | |
| VEEV | M164-16 | F | 7.1 | S | 29.55 | <0.00001 * |
| M165-16 | F | 6.9 | S | 164.7 | <0.00001 * | |
| M170-16 | M | 6.3 | S | 48.40 | <0.00001 * | |
| M171-16 | M | 6.0 | S | 84.17 | <0.00001 * |
Statistics and p-values for QRS complex for EEEV and VEEV-infected macaque cohorts. £ Doses in log10 pfu. δ TTD = Time to death. “S” denotes survivor. * p-value lower than significance level α = 0.05.